The Growing Trend of Prescribing Antipsychotics for Young People in Finland, 2000 to 2010
Open Access
- 30 November 2015
- journal article
- Published by Walter de Gruyter GmbH in Scandinavian Journal of Child and Adolescent Psychiatry and Psychology
- Vol. 4 (1) , 31-35
Abstract
Background: According to previous reports from many countries (e.g., the United States, Germany, the United Kingdom), the use of antipsychotic drugs has increased among young people. Antipsychotics have also increasingly been prescribed for non-psychotic disorders. Objective: The purpose of this study was to estimate the rate at which antipsychotics were prescribed for young people in the age groups of 10 to 14 years, 15 to 19 years, and 20 to 24 years in Finland in the years 2000, 2005, and 2010. Methods: This was a nationwide register study using data from the databases of Statistics Finland and the Finnish National Prescription Register. Statistics Finland’s databases provided background information, including the total number of young people and the Finnish National Prescription Register keeps record of all drug orders reimbursed by the Social Insurance Institution of Finland. Results: The prescription of antipsychotics grew 6.8-, 4.6-, and 2.6-fold over the study period for these three age groups, respectively. For the youngest age group, use was more common among males than females in all three periods studied. During the course of the study period, the use of antipsychotics became more common among females: in 2010, antipsychotics were more commonly used among females than males in both the 15- to 19-year-old age group and the 20- to 24-year-old age group. The younger the patient, the higher the probability that the indication for medication was a non-psychotic disorder. Conclusions: In Finland, the trends involved in the prescription of antipsychotic medications resemble those seen in many Western countries. Therefore, it is important that the safety and effectiveness of these pharmaceuticals be investigated among young people as well.Keywords
This publication has 14 references indexed in Scilit:
- The Dramatic Rise in Neuroleptic Use In Children: Why Do We Do It and What Does It Buy Us? Theories from Inpatient Data 1988–2010Journal of Child and Adolescent Psychopharmacology, 2013
- National Trends in the Office-Based Treatment of Children, Adolescents, and Adults With AntipsychoticsArchives of General Psychiatry, 2012
- Antipsychotic Medication Prescribing Trends in Children and AdolescentsJournal of Pediatric Health Care, 2012
- Antipsychotic prescribing trends: a review of pharmaco‐epidemiological studiesActa Psychiatrica Scandinavica, 2009
- Psychotropic Medication in Children and Adolescents in Germany: Prevalence, Indications, and Psychopathological PatternsJournal of Child and Adolescent Psychopharmacology, 2009
- Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concernsEuropean Neuropsychopharmacology, 2009
- Off-label psychopharmacologic prescribing for children: History supports close clinical monitoringChild and Adolescent Psychiatry and Mental Health, 2008
- Epidemiologic Features of Antipsychotic Prescribing to Children and Adolescents in Primary Care in the United KingdomPediatrics, 2008
- Monitoring and management of antipsychotic-related metabolic and endocrine adverse events in pediatric patientsInternational Review of Psychiatry, 2008
- Side Effects of Second-Generation Antipsychotics: The Experiences, Views and Monitoring Practices of Australian Child PsychiatristsAustralasian Psychiatry, 2008